Business Listings

Prostate Cancer Early Detection Investment Opportunity

Newland Global Group is delighted to present an investment opportunity, on behalf of our client, within the healthcare sector, for the early detection of prostate cancer. 

Breast Cancer Early Detection Investment Opportunity

Newland Global Group is delighted to present an investment opportunity, on behalf of our client, within the healthcare sector, for the early detection of Breast Cancer via a definitive blood test which, could revolutionise the way we prevent and manage breast cancer.

Australian Iron Ore Investment Opportunity

Newland Global Group is delighted to present an investment opportunity, on behalf of our client, within the mining sector, for an Iron Ore mining project in South Australia.

Cancer Therapeutics Immune System Response Solution

Our client is a UK-based clinical stage immune – oncology company that has identified a novel and valuable cancer target marker that only appears on the cell surface of a wide range of cancers including Lung, Breast, Colorectal, and Prostate, but is absent in healthy tissue.

Cancer Treatment Technology Investment Opportunity

Newland Global Group is delighted to present an investment opportunity, on behalf of our client, within the healthcare sector, for Cancer Treatment Technology. 

AI Enhanced Pulmonary and Cardiothoracic Imaging Technology Platform

Our client is a medical imaging software company that has developed a fully automated 3D visualization solution for quantitative Lung imaging diagnostics. Our client utilises Artificial Intelligence to turn standard greyscale medical imaging into rich visual maps of patient conditions with detailed quantitative reports that transform the way patients are discovered, diagnosed and treated.

BEAMS - Hospital Bedside Equipment Alarm and Monitoring System

NGG is delighted to offer this opportunity to invest in BEAMS (Bedside Equipment Alarm and Monitoring System) which, enables hospital staff to improve patient safety and provide higher quality patient outcomes.

Radio Frequency Testing Utilising Disruptive Technologies

NGG is delighted to offer this opportunity to invest in a Radio Frequency Testing Company Utilising Disruptive Technologies.